The Pharmaceutical Journal
Vol 280 No 7492 p271
8 March 2008

This article
Reprint   Photocopy

PDF 100K, Acrobat Reader

Products

Accessing SPCs
The summaries of product characteristics and patient information leaflets for medicines licensed in the UK are available online

Prescription products
• Fucibet
SPC changes
• Genotropin
• Reyataz
Discontinued products
• Bumetanide
• Clinoril
• Retin-A
• Tagamet
Products miscellany
• Baxter oncology products
• Cetraben cream
• Terbinafine cream

Medical deveice alert SmartCheck INR system

Prescription Products

Fucibet
Fucibet (fusidic acid 2 per cent, betamethasone valerate 0.1 per cent) lipid cream is now available from LEO Pharma.

Net price: 30g, £5.62
Legal category: POM

Back to Top

SPC changes

Genotropin
Information about treatment in the transition phase which follows the growth phase in childhood-onset growth hormone deficiency (GHD) has been added to the summaries of product characteristics for Genotropin (somatropin) and Genotropin Miniquick. The SPC now states that where childhood-onset GHD persists into adolescence, treatment should be continued to achieve full somatic development.

Reyataz
Reyataz (atazanavir) is now contraindicated for use in combination with products containing St John’s wort in Reyataz’s summary of product characteristics. The SPC also now states that co-administration of Reyataz with proton pump inhibitors is not recommended.

Back to Top

Discontinued products

Bumetanide
LEO Pharma has discontinued its bumetanide oral solution 0.2mg/ml.

Further information on 01844 347333.

Clinoril
Merck Sharp and Dohme has discontinued Clinoril (sulindac) tablets 100mg.

Further information on 01992 467272.

Retin-A
Janssen-Cilag has discontinued Retin-A (tretinoin) cream 0.025 per cent. Retin-A gel 0.01 per cent and 0.025 per cent remain available.

Further information on 01494 567567.

Tagamet
GlaxoSmithKline will be discontinuing Tagamet (cimetidine) 200mg/2ml ampoules.

Further information on 0800 221441.

Back to Top

Products miscellany

Baxter oncology products
Baxter will no longer be using the brand names of a number of its oncology products and will be using the generic names of these medicines instead. The order codes, formulation, prescribing information, administration, dosage and reconstitution of these products remain unchanged.

The products affected are:

• Mitoxana (ifosfamide) injection 1g and injection 2g
• Uromitex (mesna) tablets 400mg, tablets 600mg, injection 400mg and injection 1g
• Endoxana (cyclophosphamide) tablets 50mg, injection 500mg and injection 1g

Further information on 01635 206345.

Cetraben cream
Cebraben cream in 1050g pump presentation is now available from Genus Pharmaceuticals.

Net price: £11.11
Legal category: GSL

Terbinafine cream
Terbinafine hydrochloride cream 1 per cent is now available from Pliva.

Net price:
7.5g, £3
15g, £4.37
30g, £7.88

Legal category: GSL (7.5g and 15g), POM (30g).

Back to Top